NGAL Rapid ELISA Kit
NGAL (neutrophil gelatinase associated lipocalin) is a new early marker for acute kidney injury. NGAL levels rise within 2 hours after injury and has been used to assess patients after cardiac surgery,renal transplantation and procedures involving the use of i.v. contrast media. Our CE-IVD-marked NGAL Rapid ELISA Kit measures human NGAL in urine, plasma or serum. The positive predictive value for acute renal failure is over 90%.
Monkey (Cynomolgus) NGAL sandwich ELISA pair launched
BioPorto Diagnostics has developed at sandwich ELISA pair for detection of monkey (Cynomolgus) NGAL. Click here to view the product specification.
The next addition to our NGAL product portfolio will be an antibody pair against murine NGAL to allow the setting up of a sandwich ELISA. Our anti-mouse NGAL antibodies will complement our Rat NGAL ELISA Kit and our monkey NGAL antibodies and enable researchers to measure NGAL in the most common pre-clinical animal models.
Sign up to be notified when mouse NGAL antibodies are available
Rat NGAL ELISA Kit launched
NGAL determination allows kidney injury to be detected almost as soon as it occurs. Rats are among the most frequently used laboratory animals for research on kidney damage. The rat NGAL test can thus be used in the development of new treatments for kidney damage, to detect nephrotoxic side effects of new drugs, and for basic science research on kidney injury and kidney diseases. It is therefore expected that the use of NGAL as a toxicological marker of kidney damage in rats could prove to be of considerable importance in the preclinical evaluation of new pharmacological products, as it is much cheaper and easier to determine NGAL than to carry out a microscopic examination of the kidney itself, which is the typical experimental end-point today.
